Turpaz Industries (TRPZ) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
3 Nov, 2026Executive summary
Record Q1 sales were $60.359M, up 54.7% YoY, with 9.1% organic growth and acquisitions contributing.
Adjusted EBITDA rose 62.7% to $13.615M; reported sales CAGR was 33.2% from Q1 2021 to Q1 2025.
Financial highlights
Revenue was $60.359M vs. $39.016M; gross profit was $23.519M vs. $14.396M.
Operating profit increased to $9.634M from $5.453M; net profit rose to $5.410M from $3.308M.
Non-GAAP net profit was $7.877M vs. $4.858M; operating cash flow was $7.564M vs. $3.550M.
Basic and diluted EPS rose to $0.04 from $0.03; Q1 2025 net profit excluded no discontinued-operations amount.
Foreign-exchange effects reduced sales growth by 1.5%.
Outlook and guidance
Sales growth continued into Q2 2025; improvement in Specialty Fine Ingredients sales was expected to continue during 2025.
Strategy targets double-digit growth through acquisitions and organic expansion, with further acquisitions and synergy capture planned.
Latest events from Turpaz Industries
- Record Q1 growth was led by Taste and acquisitions, while Specialty Fine Ingredients weakened.TRPZ
Q1 2024 - Acquisitions and Taste/Scent growth lifted record results despite Specialty Fine Ingredients weakness.TRPZ
Q2 2024 - Acquisition-led growth lifted sales and adjusted EBITDA as Specialty Fine Ingredients weakened.TRPZ
Q3 2024 - FY24 sales rose 48.4%, with adjusted EBITDA up 54.8%.TRPZ
Q4 2024 - Q2 sales grew 35.6%, with 14.2% organic growth and a 23.1% adjusted EBITDA margin.TRPZ
Q2 2025 - Q3 sales rose 57.4% as organic growth and acquisitions lifted adjusted EBITDA 55.1%.TRPZ
Q3 2025 - Revenue rose 45.6% in 2025 as adjusted EBITDA margin reached 23.1%.TRPZ
Q4 2025 - Q1 revenue rose 38.6%; Phoenix and Romessence lifted the sales run rate to $380m.TRPZ
Q1 2026 - Acquisitions and organic growth drove record sales, while integration and production ramp-up shape the outlook.TRPZ
Q2 2026